| NCT Number | NCT07296211 |
| Lead Sponsor | NYU Langone Health |
| Conditions | Type2 Diabetes Mellitus |
| Enrollment | 480 participants |
| Start Date | 2026-01 |
| Primary Completion | 2028-12 (estimated) |
| Study Completion | 2029-06 (estimated) |
| Updated on ClinicalTrials.gov | 2025-12-22 |